EGFR and cancer: EGFR is frequently mutated in cancer, its hyperactivation confers a survival benefit to cancer cells and has been established as a resistance marker to standard cancer therapy.70, 71, 72, 73, 74 Interestingly, activation of EGFR has been shown to be necessary for the replication of several OVs and exploited to improve OV selectivity toward cancer cells.